Unresolved cancer mechanism: Integrative Multi-Omics Analysis Reveals HNRNPLL as a Potential Biomarker Associated with Hepatocellular Carcinoma Progr

OPEN

Literature-mined gap from: "Integrative Multi-Omics Analysis Reveals HNRNPLL as a Potential Biomarker Associated with Hepatocellular Carcinoma Progression" (Wang X et al., Metabolites 2026; PMID 42042880). The paper signals unresolved mechanistic uncertainty in a cancer context.

Priority: 0.60 Domain: oncology-literature Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Unresolved cancer mechanism: Integrative Multi-Omics Analysis Reveals HNRNPLL as a Potential Biomarker Associated with Hepatocellular Carcinoma Progr is a 0.6 priority gap in oncology-literature. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Unresolved cancer mechanism: Integrative Multi-Omics Analysis Reveals HNRNPLL as a Potential Biomarker Associated with Hepatocellular Carcinoma Progr — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (28)

NF-ΚBCarcinomaP53CarcinomaUBIQUITINCarcinomaPTENCarcinomaINFLAMMATIONCarcinoma
▸ Show 23 more

expressed in (2)

CANCERCarcinomaGENESCarcinoma

inhibits (3)

APOPTOSISCarcinomaCANCERCarcinomaCarcinomaApoptosis

regulates (1)

CANCERCarcinoma

targeted by (1)

Biomarkerh-var-3049fa9ae4

targets (1)

h-var-3049fa9ae4Biomarker

therapeutic target (14)

CANCERCarcinomaEGFRCarcinomaAUTOPHAGYCarcinomaAPOPTOSISCarcinomaINFLAMMATIONCarcinoma
▸ Show 9 more
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps